Huw M. Nash, Ph.D.

Chief Business Officer


Huw Nash is the chief business officer of Stoke Therapeutics and was previously the founding chief executive officer and chief operating officer. An entrepreneur-in-residence at Apple Tree Partners focused on novel therapeutics, Huw has 20 years of experience establishing, funding and growing startup biotechnology companies. Prior to Stoke, Huw was a co-founder and vice president of corporate development for Aileron Therapeutics. He was also a founding scientist of NeoGenesis Pharmaceuticals, where he served as vice president of external collaborations prior to the company’s acquisition by Schering-Plough. Huw received his B.A. in biochemical sciences from Harvard College and earned his Ph.D. in organic chemistry from Harvard University.

Stoke Leaders in the News

Dr. Nash and TANGO Featured in Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology News published an article about the history of and recent interest in mRNA-based medications.based in part on an interview with Stoke's Chief Operating and Business Officer, Huw M. Nash, Ph.D.